Yourgene Health PLC
LSE:YGEN

Watchlist Manager
Yourgene Health PLC Logo
Yourgene Health PLC
LSE:YGEN
Watchlist
Price: 0.515 GBX
Market Cap: £16.4m

Net Margin

-27.6%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-27.6%
=
Net Income
£-8.2m
/
Revenue
£29.7m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-27.6%
=
Net Income
GBX-8.2m
/
Revenue
£29.7m

Peer Comparison

Country Company Market Cap Net
Margin
UK
Yourgene Health PLC
LSE:YGEN
16.4m GBP
Loading...
US
Abbott Laboratories
NYSE:ABT
189.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
190.1B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
138.7B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.1B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
130.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.5B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.9B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.3B USD
Loading...

Market Distribution

Lower than 95% of companies in United Kingdom
Percentile
5th
Based on 3 670 companies
5th percentile
-27.6%
Low
-188 120% — 0%
Typical Range
0% — 0.1%
High
0.1% — 10 443.9%
Distribution Statistics
United Kingdom
Min -188 120%
30th Percentile 0%
Median 0%
70th Percentile 0.1%
Max 10 443.9%

Yourgene Health PLC
Glance View

Market Cap
16.4m GBX
Industry
Health Care

Yourgene Health Plc engages in the development and commercialization of genomic services and technologies. The principal activity of the Company is that of a molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for prenatal screening and other clinical applications in the early detection, monitoring and treatment of disease. The firm operates through two segments. The Genomic Technologies segment provides the in vitro diagnostic products, software and instrumentation manufactured by the Company and distributed globally through its direct and indirect sales channels. The Genomic Services segment operates testing laboratories in Taiwan and the United Kingdom and provides services to clinicians, third party clinical service providers and contract research organizations. These services require similar technical, commercial and managerial competences in the two host countries, and sometimes consume the output from the Genomic Technologies segment.

YGEN Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-27.6%
=
Net Income
£-8.2m
/
Revenue
£29.7m
How has Net Margin changed over time?

Over the last 3 years, Yourgene Health PLC’s Net Margin has decreased from 42.6% to -27.6%. During this period, it reached a low of -66.6% on Mar 31, 2021 and a high of 42.6% on Aug 30, 2019.

Back to Top